Literature DB >> 11870952

Stent-based antirestenotic coatings (sirolimus/paclitaxel).

Martin Oberhoff1, Christian Herdeg, Andreas Baumbach, Karl R Karsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11870952     DOI： 10.1002/ccd.10034

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


× No keyword cloud information.
  4 in total

1.  HPLC-MS/MS method for quantification of paclitaxel from keratin containing samples.

Authors:  Emily A Turner; Alexandra C Stenson; Saami K Yazdani
Journal:  J Pharm Biomed Anal       Date:  2017-03-10       Impact factor: 3.935

2.  A chemical stability study of trimethylsilane plasma nanocoatings for coronary stents.

Authors:  John Eric Jones; Qingsong Yu; Meng Chen
Journal:  J Biomater Sci Polym Ed       Date:  2016-10-19       Impact factor: 3.517

3.  Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation.

Authors:  Xin Du; Jun-ping Kang; Jia-hui Wu; Qiang Lv; Chao-shu Tang; Chang-sheng Ma
Journal:  J Zhejiang Univ Sci B       Date:  2010-08       Impact factor: 3.066

4.  In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons.

Authors:  Emily Turner; Megan Erwin; Marzieh Atigh; Uwe Christians; Justin M Saul; Saami K Yazdani
Journal:  Front Pharmacol       Date:  2018-07-30       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.